|Bid||87.41 x 900|
|Ask||88.14 x 1100|
|Day's Range||87.15 - 88.58|
|52 Week Range||81.66 - 100.15|
|Beta (3Y Monthly)||0.66|
|PE Ratio (TTM)||24.78|
|Forward Dividend & Yield||2.00 (2.25%)|
|1y Target Est||N/A|
At least two other companies are likely to soon depart the state's roster of Fortune 500 companies, which has long been a regional point of pride.
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tandem Diabetes is the IBD Stock Of The Day after the medical device company knocked its first-quarter results out of the park this month. Now, Tandem stock is approaching a breakout.
As uncertainty over the outcome of Sino-American trade talks grows, so does the possibility of a longer-than-expected negotiations or an all-out trade war, strategists at Goldman Sachs are providing some timely trading strategies.
According to Medtronic (MDT), interbody implants material and shape play a vital role in the bone growth process during fusions and presently, titanium interbody devices are rapidly becoming popular.
[Editor's note: This story was previously published in February 2019. It has since been updated and republished.]Investing to "buy and hold" is trickier than it looks. The increasing pace of technological change means even the most successful, dominant companies have to continually adapt to keep up. Industries like energy, real estate and even consumer products are facing potentially significant long-term changes going forward. In any era, amassing a collection of retirement stocks simply by buying the best companies and holding them for years can be a risky endeavor.General Motors (NYSE:GM) was a classic "widows and orphans" stock until last decade, when GM wound up going bankrupt. United States Steel (NYSE:X) once was a pillar of corporate America and a buy-and-hold stock. GM shares basically haven't moved in a quarter of a century. Polaroid and Eastman Kodak were once blue-chip stocks. Both went bankrupt as cameras changed from film to digital.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut there still are stocks to buy and hold out there that can last forever, while offering dividend income along the way. * 7 Dividend Stocks to Buy as the Trade War Reignites Here are ten such retirement stocks to hold forever.Source: Shutterstock Bank of America (BAC)Dividend Yield: 2%It might seem strange to open the list with Bank of America (NYSE:BAC). After all, we're only a bit more than a decade on from the financial crisis. During that crisis, BofA acquisition Countrywide Financial blew up in spectacular fashion, after pioneering many of the risky tactics that led to the bubble and subsequent bust.But this is a different BofA.Net consumer charge-offs hit a decade-long low last year. Its performance on credit metrics is strong. Government regulations have been criticized as slowing growth -- but they've undoubtedly lowered risk as well, even if observers might argue that a better balance is needed.No less than Warren Buffett is now BofA's largest shareholder, through his Berkshire Hathaway Inc. (NYSE:BRK.A, NYSE:BRK.B). And the Oracle of Omaha is fond of saying that his favorite holding period is "forever."That seems likely true for BAC stock as well.Source: Mustafa Khayat Via Flickr Diageo (DEO)Dividend Yield: 1.6%Change has come to the alcohol industry, with the number of breweries exploding worldwide and new distilleries popping up as well. The brands owned by Diageo (NYSE:DEO) are well-positioned to adapt to shifting tastes.Diageo owns classic brands like Johnnie Walker whisky, Tanqueray gin, Smirnoff vodka, and Harp and Guinness beer, among many others. What most have in common is a timeless quality and worldwide brand recognition. As a result, while beverage giants like Coca-Cola (NYSE:KO) and Anheuser Busch InBev (NYSE:BUD) have struggled with earnings growth, Diageo grew net income by 13.5% in fiscal 2018 and expects consistent growth going forward. * 7 Dividend Stocks to Buy as the Trade War Reignites Yet with a forward multiple of 25, and with a dividend yield approaching 2%, Diageo stock isn't all that dearly valued. Long-term investors would do well to own DEO and perhaps use the dividends to buy a bottle or two of fine whisky.Source: U.S. Embassy Kyiv Ukraine via Flickr (Modified) Medtronic (MDT)Dividend Yield: 2.3%In this day and age, the U.S. healthcare market in particular seems potentially volatile. Concerns about increased spending and political battles over the Affordable Care Act create more questions than answers.But even with that uncertainty, Medtronic (NYSE:MDT) isn't going anywhere. The company's devices are an integral part of modern medicine, ranging from pacemakers to stents to bone grafts to imaging systems.Even the risks involved in the sector look priced into MDT. Medtronic's days of double-digit annual growth may well be behind it, but it's not finished increasing earnings or dividends. MDT stock likely isn't finished rising, either.Source: Shutterstock NextEra Energy (NEE)Dividend Yield: 2.6%Utility stocks are among the most common safe, buy-and-hold stocks. NextEra Energy (NYSE:NEE) is now the largest electric utility in the U.S. by market capitalization. That might actually be the only problem with NEE stock.NextEra shares gained 10.5% year-to-date, and trades just off record highs. Potential valuation concerns aside, NextEra looks like a winner. It serves customers in the southern Florida region, still one of the nation's fastest-growing areas. A 21x forward P/E multiple is high for the space but not outlandishly so. And a 2.6% dividend yield provides income along the way. * 7 Dividend Stocks to Buy as the Trade War Reignites Investors looking for value in the space might look for a smaller play like cheaper Dominion Energy (NYSE:D). But it's usually worth paying for quality, and NextEra Energy looks like one of the best utility stocks out there.Source: Blue Genie via Flickr McCormick & CompanyDividend Yield: 1.7%McCormick & Company (NYSE:MKC) is another quality company whose valuation might spook some investors. But MKC stock very rarely is offered cheaply.The company's market leadership in spices and seasonings provides both an impressive moat and protection against economic downturns. MKC stock did dip after the company acquired French's mustard and Frank's RedHot sauce from Reckitt Benckiser (OTCMKTS:RBGLY) at a price that looked a bit high to many investors. But MKC has recovered those gains and then some.Top-line growth for McCormick likely isn't going to be explosive, but it will be steady. The same has been true of MKC stock, which has returned an average of 13% a year over the past decade, including dividends.With continuous cost-cutting initiatives, the contribution from the acquired brands and organic growth (and growth in organic products), MKC still should be able to provide double-digit annual returns going forward as well.Source: Shutterstock Allstate CorpDividend Yield: 2.1%Allstate Corp (NYSE:ALL) long has used the tagline, "You're in good hands," and it's true for Allstate investors as well. ALL stock has almost quadrupled from late-2011 lows. And there could be more upside to come.After all, Allstate isn't particularly expensive, trading at a 13.75 P/E. * 7 Dividend Stocks to Buy as the Trade War Reignites Once any short-term worries subside, ALL should resume its march upward.Source: Shutterstock International Flavors & Fragrances (IFF)Dividend Yield: 2.21%International Flavors & Fragrances (NYSE:IFF) is a company most consumers encounter every day without knowing it and many investors aren't exactly hip to it, either.As its name suggests, the company develops flavors & fragrances across 13 categories, including cosmetics, perfumes, beverages and sweet flavors. Sales and earnings have increased consistently and so has IFF's share price. At a 41.75 P/E, IFF does look a bit pricey. But, as with McCormick and other stocks on this list, investors should pay for quality.IFF's hidden, but key role, in so many industries, gives it a great deal of protection against both competition and macro factors. Acquisitions and a growing cosmetic additive business both provide room for growth.Consumers may not know IFF, but investors should.Source: Shutterstock Lamb WestonDividend Yield: 1.15%Lamb Weston (NYSE:LW) was spun off from Conagra Brands (NYSE:CAG) last year. Lamb Weston is the No. 1 potato producer in the United States. In fact, it manufactures the well-known fries at McDonald's (NYSE:MCD), among other restaurant chains.Lamb Weston also has a consumer business (including a small segment that manufactures frozen vegetables), while serving restaurants of all sizes. Health concerns might seem a long-term headwind against the business, but growth has been steady for years, and margins continue to improve.LW is targeting international markets for growth, as French fries have much more limited penetration, while international audiences generally are intrigued by Americanized products.Despite growth and leading market share, LW stock isn't particularly cheap, trading at about 19 times next year's earnings. The company did pick up a fair amount of debt in the CAG spinoff. But it's paying that debt down, which should lower interest expense and boost cash flow going forward. * 7 Stocks With Too Much Riding On China With many similar stocks trading at much higher multiples, LW seems to have room for upside. And international growth should offset any health-related concerns in the U.S., should they arise. America's love affair with French fries isn't going to suddenly end, and that should ensure years of stability for Lamb Weston at least.Source: Shutterstock Fortune Brands (FBHS)Dividend Yield: 1.67%Investors are commonly advised to diversify their portfolio. Fortune Brands Home & Security (NYSE:FBHS) has done just that. The company operates in four segments: Cabinets, Plumbing, Doors, and Security. Among its well-known brands are Moen in plumbing, and MasterLock in security.FBHS is more of a cyclical stock than most on this list, and the company no doubt has benefited from the steady, if slow, housing recovery in the U.S. But the company's products also generate relatively stable replacement demand, and a 1.67% dividend yield provides modest, but growing, income.Fortune Brands has been an impressive company since its founding and a solid stock since its 2011 IPO. There may be a bit more volatility here, but that's a worthwhile price to pay for long-term investors. There's enough value in Fortune Brands to ride out any market jitters.Source: Shutterstock Dividend Yield: 1.81%Republic Services (NYSE:RSG) is a bit smaller and likely a lot less well-known than rival Waste Management (NYSE:WM). But in this case, that's not necessarily a bad thing.Republic Services has outgrown its larger competitor in both sales and earnings over the past five years. RSG stock has modestly outperformed WM over the same period as well. Investors appear to believe that will continue, as Republic Services is valued a bit higher than Waste Management, at least based on forward earnings multiples.Both RSG and WM are solid long-term plays. Contracted revenue and steady demand should support both companies for years to come. There's room for further acquisitions in a relatively fragmented space. Republic Services gets the nod here due to slightly better growth and more room for margin improvement. * 7 Dividend Stocks to Buy as the Trade War Reignites But investors looking for safe, stable growth can't go wrong with either RSG or WM.As of this writing, Vince Martin was long MKC. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Dividend Stocks to Buy as the Trade War Reignites * 10 Stocks That Could Squeeze Short Sellers, Including CGC * 5 Tech Stocks Getting Crushed Compare Brokers The post 10 'Buy-and-Hold' Stocks to Own Forever appeared first on InvestorPlace.
Medtronic said Thursday it will acquire Titan Spine, a medical-device manufacturer that makes titanium implants for spine fusion surgeries.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 9) Alcon AG (NYSE: ALC ) ANI Pharmaceuticals Inc (NASDAQ: ...
Medtronic has left the orthopedic-implant market more than two years after announcing it would begin to operate in the arena.
In most cases, trying to pinpoint the best entry spot into a new position is a lost cause. Either a stock doesn't ebb and flow predictably enough, or waiting ends up meaning a trader ultimately misses out on gains. The market's very best stocks have a knack for making prolonged rallies, never pulling back and opening a window of opportunity.There are exceptions, however. That is to say, some stocks are forever rising and falling in a pattern, making long-term net progress, even if not rising in a straight line. * 10 Lithium Stocks to Buy Despite the Market's Irrationality To that end, here's a rundown of the market's best stocks to buy on a decent dip. They're not necessarily ripe for a purchase right now, but they each sport enough long-term momentum and the right fundamentals to recover from a future stumble as well as they have in the past.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Johnson & Johnson (JNJ) Click to EnlargeJohnson & Johnson (NYSE:JNJ) stock may not always soar to higher highs. But, even when the market environment is lousy and the economy is in shambles, JNJ stock finds a way of hammering out some degree of progress. Its stumbles are always short-lived before yielding to a move above its prior peak.That persistence has everything to do with the nature of its business. Johnson & Johnson sells a mix of prescription drugs, over-the-counter drugs like Tylenol and Zyrtec and a variety of medical equipment. Its top and bottom lines don't move in a perfectly straight line, but they broadly move higher all the time.There is a catch with JNJ stock, however. While it can and usually does recover pretty quickly, there's no rhythm or pattern to its pullbacks and rebounds. Verizon Communications (VZ) Click to EnlargeThe telecom industry is changing. It's getting tougher to be in, as the lines between phone and video -- and now entertainment -- continue to blur.Nobody knows that better than the chiefs at Verizon Communications (NYSE:VZ), which acquired a struggling Yahoo with plans to use that as a springboard into the streaming video arena. It has not worked out very well, with the company writing down $5 billion last year to adjust for the deteriorating value of its Yahoo and AOL properties.Unlike its biggest rival AT&T (NYSE:T), however, Verizon hasn't taken on too much outside of the telecom realm. Revenue growth has been surprisingly steady, even if income growth hasn't been quite as consistent. It's the erratic bottom line largely responsible for the pullbacks the stock has been dishing out since 2010. * 10 Vice Stocks to Spice Up Your Portfolio Take a closer look at those lulls though. Just when it looks like the stock's never going to recover, it does. Goldman Sachs Group (GS) Click to EnlargeGoldman Sachs Group (NYSE:GS) used to be a titan, and arguably the premier name in the investment banking business. That's not the case anymore. Through a combination of more competition and a lack of effective focus, Goldman lost a step.Investors have taken notice. It was earnings lulls that largely drove the 2011, 2015 and 2018 setbacks for GS stock. Those were big selloffs too. Last year's tumble was almost a 50% meltdown from peak to trough.Those troughs have been great buying opportunities though, since if nothing else, Goldman Sachs can lean on its pedigree while it regroups to restore earnings growth. There's also a support line that appears to be playing a role in the stock's recoveries now. Lowe's Companies (LOW) Click to EnlargeHardware store chain Lowe's Companies (NYSE:LOW) has always played second fiddle to bigger rival Home Depot (NYSE:HD), and perhaps hasn't performed as well as it would have liked because Home Depot was forever standing in the way.The second-biggest home improvement retailer is no slouch, however. As long as the economy and housing market are on solid footing, Lowe's is growing too, securing its spot on a list of the best stocks to buy on a dip. * 7 Tips for Financial Planners to Gain a Competitive Edge The weekly chart of LOW confirms it. The weekly chart also makes clear that this particular stock ebbs and flows in a rhythm, and more often than not, it turns around when it bumps into previously established support and resistance lines. Medtronic (MDT) Click to EnlargeMedtronic (NYSE:MDT) makes and markets a variety of medical devices, ranging from pacemakers to dialysis catheters to electrosurgical instruments.Yes, as was the case with Johnson & Johnson, Medtronic's business is reliable from one quarter -- and one year -- to the next. The tradeoff is, red-hot growth is incredibly unlikely.It's a dynamic investors generally have a tough time remembering, given the stock's up-and-down action. The market will bid it up to unsustainable values, and when they correct that move, they overdo the downturns as well. The end result is a relatively well-established zig-zag pattern that since 2015 has been framed by equally well-established support and resistance lines.It looks as if MDT shares just pushed up and off the lower boundary of that rising trading range. WEC Energy Group (WEC) Click to EnlargeThere's rarely a bad time to own a utility stock. While they offer little in the way of growth, they offer much in the way of consistency. They're also solid dividend payers, even if they rise and fall like bonds when interest rates fall and rise.WEC Energy Group (NYSE:WEC) isn't an exception to that norm.Yes, it's a bit off the radar. WEC Energy serves only 4.5 million customers in Wisconsin, Illinois, Michigan and Minnesota. * 7 ETFs for Investors With a Gambler's Spirit That obscurity is the edge investors have, however. It's not overwatched and overinvested the way bigger names like Southern Co (NYSE:SO) and Duke Energy (NYSE:DUK) are. That dynamic allows it to move without an unnatural level of buying and selling pressure; instead, moving back and forth in a well-established pattern clearly framed by support and resistance levels. It just bumped into the upper boundary of that ceiling, so investors looking to step in will probably have to wait a while. Dollar Tree (DLTR) Click to EnlargeDollar Tree (NASDAQ:DLTR) is a curious bird. One would think the deep discounter would thrive when the economy is in shambles and struggle when the economy is thriving.That has not necessarily been the case though. In fact, there has been no apparent link to the economy in a long time for DLTR stock. It just moves higher in any kind of environment, in step with unfettered sales and earnings growth. Last quarter's slight sales lull is the first time since 2014 the top line has shrunk. Before that, it hadn't happened since the end of 2007. That consistency is the key reason DLTR has earned a spot on a list of the best stocks to buy after a pullback.Just for the record, however, the pullbacks Dollar Tree shares are dishing out on a regular basis are uncomfortably big. The trip from the upper edge of a long-term trading range to the lower end of that range last year cut DLTR by about a third of its value. Coca-Cola (KO) Click to EnlargeConsumers may be steering away from sugary sodas, but that's hardly all Coca-Cola (NYSE:KO) is anymore. Dasani water, Honest T tea and Zico coconut water are just some of its healthier options that consumers are clamoring for these days. That diverse product lineup is a key reason the company's sales and earnings have been predictable, even if not always moving forward.The beverage business runs (no pun intended) hot and cold, and that can push KO stock higher and lower by quite a bit. * 7 Marijuana Stocks That Are Bleeding Cash Take a step back and look at the weekly chart though. You'll find that what feels like sizeable pullbacks at the time ends up being opportunities to step into a long-term uptrend right as the lower boundary of a rising channel is met. Micron Technology (MU) Click to EnlargeShares of Micron Technology (NASDAQ:MU) ebb and fall regularly too, but their cycle can take an agonizingly long time to complete. Whereas other names that make for great "buy on a dip" prospects may peel back for a few weeks, Micron shares can slide for over a year.In every case so far, though, the recovery has more than offset the setback.The cycle in question is neither a psychological nor an economic one. It's a tech-based one. The computer memory market is in the nasty habit of over-responding to rising RAM prices, creating too much production capacity that leads to a price-gouging glut. That's what up-ended MU stock in 2018, and again last year.The tough part about using these selloffs is being patient enough to let them run their full course before filing back in. United Parcel Service (UPS) Click to EnlargeFinally, add United Parcel Service (NYSE:UPS) to your watchlist of stocks to buy after a major pullback.UPS contends with a variety of headwinds, ranging from economic lulls to fuel prices to competitive pressures. None of them are easy, and all of them are capable of taking a toll on United Parcel Service shares with or without notice. The weekly chart of UPS is visibly, alarmingly erratic. * 10 Tech Stocks to Buy Now for 2025 Take a closer look at that chart though. While sea-sickening at times, all of the dips since 2009 have been great short-term buying opportunities. Several of them wound up being great long-term entry points. The challenge is just mustering the guts to take the swing, trusting that United Parcel Service is capable of addressing its challenges immediately after they surface. So far, it has been.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Strong Buy Stocks That Tick All the Boxes * 7 Stocks to Buy From the T. Rowe Price Health Sciences Fund * 5 Tech ETFs to Plug In to Big Profits Compare Brokers The post 10 Great Stocks to Buy on Dips appeared first on InvestorPlace.
Medtronic PLC NYSE:MDTView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for MDT with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MDT. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.70 billion over the last one-month into ETFs that hold MDT are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Health-care stocks have had a tough year so far. But Medtronic, UnitedHealth Group, and Quest Diagnostics are three for income investors to consider.
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
While gurus hold positions in these companies, the share price and returns continue to fall. The share price of $63 is 20.93% below its 52-week high and 4.36% above its 52-week low. The return on equity of 25.50% and return on assets of 8.29% are outperforming 79% of companies in the Drug Manufacturers - Major industry.
Intuitive Surgical (NASDAQ:ISRG) stock has started off 2019 in great fashion with back-to-back FDA approvals. In February, the U. S. FDA granted clearance for Ion, and in March it cleared da Vinci SP for certain transoral ear, nose, and throat procedures.Source: Jon Fingas via Flickr (Modified)There have been concerns over big tech firms like Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG) entering the space , but ISRG stock has decidedly shaken off those worries. It's also shaken off competition from other medical-device companies. * 7 Healthy Dividend Stocks to Buy for Extra Stability In 2019, ISRG stock has outperformed the competition--namely, Medtronic PLC (NYSE:MDT)--handily. MDT made a play to enter the space via its acquisition of Mazor Robotics last fall. Maybe MDT finally caught a glimpse into the future and realized it was going to fall behind without a drastic move in the robotics space. But this is Intuitive's court, and Medtronic is playing catch up.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe performance of ISRG stock says it all. Year-to-date, ISRG stock is up 10.5% and MDT is down 7.5%. Over the past five years, the outperformance is even more stark, proving that the market rewards innovation. ISRG stock is up an astounding 1342% during that period (as of Apr. 17), versus MDT's gain of just 48%. New Approvals Boost ISRG StockThe Ion endoluminal system has changed lung-cancer diagnosis. Doctors can now conduct minimally invasive biopsies in the peripheral lung. With the Ion system's flexible biopsy needle (called the Flexision Biopsy Needle), ISRG's technology can now access small, difficult locations in lung lesions and improve doctors' abilities to make a lung cancer diagnosis.We know that early diagnosis can save lives, and ISRG's robotic-assisted system shows how effective ISRG is in developing innovative, minimally invasive solutions and how it is extending its focus beyond surgery.The second milestone for Intuitive came on the heels of the approval of Ion; ISRG's da Vinci surgical system was approved for use in certain transoral ear,nose and throat procedures in adults. Ion provides surgeons with the ability to access deep and narrow tissue in the body through just a single, small incision.Ion utilizes a multi-jointed, wristed instruments and a fully wristed 3D HD camera. There are countless YouTube videos worth watching of the system assisting surgeons, making operations less invasive and more efficient.Ion is groundbreaking. ISRG Stock Has Momentum From ISRG's Strong Fourth QuarterISRG had an indisputably strong Q4, as its revenue rose 17% year-over-year, crossing the billion-dollar mark. The revenue jump was driven by increases in both procedures and systems sales.During the quarter, instrument and accessory revenue jumped 18% to over half a billion dollars. The volume of Da Vinci procedures grew 19% YoY. After the FDA approval for the product's use in ear, nose and throat procedures in adults this year, investors can expect to see sustained growth, propelled by new applications for the company's core da Vinci technology.In Q4, ISRG shipped 290 da Vinci Surgical Systems compared to 216 in Q4 of 2017. Not only is there more demand for the product, but surgeons are also using it more often. Worldwide, the number of da Vinci procedures grew approximately 19% year-over-year. Expect ISRG to keep posting double-digit growth figures in those areas. ISRG Stock Will Continue to RiseISRG continues to be the leader of robotic-assisted, minimally invasive surgery. The performance of ISRG stock has been wonderful and will continue to bolster investors' portfolios.ISRG's fundamentals look excellent, and the significant momentum behind the rise of ISRG stock should continue. Demand for its da Vinci technology doesn't show any sign of slowing, as the rapid growth of the elderly population increases demand for surgical procedures.Expect continued growth in the number of shipments of the da Vinci surgical system and further FDA approvals of new procedures assisted by ISRG's products.As of this writing, Luce Emerson did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post Intuitive Surgical Stock Is the Best MedTech Company to Buy and Hold appeared first on InvestorPlace.
Medical device companies like Abbott, Medtronic and Tandem Diabetes are jockeying for a piece of the diabetes treatment market, which could be worth north of $2 trillion by 2030.